Cooperation between the business sector and the health system
The activities undertaken in the research centres of the HUBc go beyond excellent clinical research conducted in conjunction with hospitals and other national centres and groups. Translational research crosses the borders of basic science and clinical application to place researchers within new contexts and to mark the beginning of a series of new contacts and relationships. This type of practice represents a much more interactive research style characterized by fewer barriers and a higher degree of permeability, which leads to improved interaction between academic research and industrial practice.
Along with the health and biomedical productive sector, translational research blurs the lines between different disciplines and sectors and directly contributes to innovation and the social impact of clinical research. So, cooperation and collaboration with industry through translational research is essential to the success of new medications and diagnostic health products. Within this context, it is also important to underscore the incorporation of key research institutes into the HUBc, such as the Institute of Photonic Sciences (ICFO), the Institute for Bioengineering of Catalonia (IBEC), because these are institutions devoted to biomedical research and biotechnological research for biomedicine that are very closely tied to the business sector, which sponsors development.
Streamlining the relationship between academia and industry through translational research is not only found in technological knowledge, which is more linked to biomedical engineering, but also in everything being undertaken in all the other healthcare institutes working with and in hospitals.
The business sector has considerable resources and incentives to translate emerging biological concepts into products, on a scale that goes beyond the abilities of the public sector, as it requires extraordinary funding to advance a medication through the initial testing phase (phases I and II) to its approval and, finally, its sale. Therefore, the private sector plays a very important role in commissioning the development and application of innovative products.
This is why it is so important that the business sector participates in the HUBc and that the project is involved in the development of pharmaceuticals and at the forefront of translational research being conducted at university hospitals and science parks. Furthermore, the private sector does not only cooperate in commissioning and investing in the development of innovations in the field of health sciences, but it also actively sponsors biomedical research and promotes the public-private cooperation crucial for scientific advancement and for the transfer of knowledge in the area of biomedicine.